Baird Medical Investment Holdings (BDMD) Receivables (2023 - 2025)

Baird Medical Investment Holdings (BDMD) has 3 years of Receivables data on file, last reported at $42.8 million in Q4 2025.

• On a quarterly basis, Receivables fell 15.96% year-over-year to $42.8 million in Q4 2025; TTM through Dec 2025 was $42.8 million, a 15.96% decrease from a year earlier, with the FY2025 full-year figure at $47.6 million, down 6.59% from the prior year.
• Receivables for Q4 2025 stood at $42.8 million, up from $40.8 million in the prior quarter.
• Over the last five years, Receivables for BDMD reached as high as $50.9 million in Q4 2024 and fell as low as $31.5 million in Q4 2023.
• Historically, Receivables has averaged $41.5 million across 3 years, with a median of $41.8 million in 2025.
• Across the five-year window, Receivables surged 61.75% in 2024 and retreated 15.96% in 2025, its largest moves.
• Year by year, Receivables stood at $31.5 million in 2023, then surged by 61.75% to $50.9 million in 2024, then retreated by 15.96% to $42.8 million in 2025.
• Per Business Quant data, the three most recent Receivables figures were $42.8 million in Q4 2025, $40.8 million in Q2 2025, and $50.9 million in Q4 2024.